metoprolol succinate tablet film coated extended release
1 INDICATIONS AND USAGE Metoprolol succinate is a beta1-selective adrenoceptor blocking agent. Metoprolol succinate extended-release tablets USP are indicated for the treatment of: Hypertension ( 1.1 ) Angina Pectoris ( 1.2 ) Heart Failure - for the treatment of stable, symptomatic (NYHA Class II or III) Heart Failure of ischemic, hypertensive, or cardiomyopathic origin.( 1.3 ) 1.1 Hypertension Metoprolol succinate extended-release tablets USP are indicated for the treatment of Hypertension. It may be used alone or in combination with other antihypertensive agents [see Dosage and Administration (2) ] . 1.2 Angina Pectoris Metoprolol succinate extended-release tablets USP are indicated in the long-term treatment of Angina Pectoris, to reduce angina attacks and to improve exercise tolerance. 1.3 Heart Failure Metoprolol succinate extended-release tablets USP are indicated for the treatment of stable, symptomatic (NYHA Class II or III) Heart Failure of ischemic, hypertensive, or cardiomyopathic origin. It was studied in patients already receiving ACE inhibitors, diuretics, and, in the majority of cases, digitalis. In this population, metoprolol succinate extended-release tablets decreased the rate of mortality plus hospitalization, largely through a reduction in cardiovascular mortality and hospitalizations for Heart Failure.
aphena pharma solutions - tennessee, llc
ROUND WHITE logo 831
logo 831 ROUND WHITE
Related Pills
metoprolol succinate tablet film coated extended release
aphena pharma solutions - tennessee, llc
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
More pills like ROUND logo 831